News

Two Humanitas Scientists Among Telethon Grant Winners for Rare Genetic Disease Research

Fondazione Telethon has announced the winners of the fourth round of its multi-round grant program, which supports cutting-edge research on...

Read more

Heart Failure: Autoimmune Mechanism in Disease Progression Enables Vaccine Therapy

A study conducted at Humanitas has uncovered that the progression of heart failure is fueled by an autoimmune response targeting...

Read more

Preclinical study explores prenatal antibiotics’ impact on breast milk and neonatal immune function

The development of gut microbiota and the immune system during the first months of life may be influenced by antibiotic...

Read more

The Revolution of Additive Manufacturing in Biomedicine

On the occasion of the inauguration of the 2024/2025 academic year, the new 3D Innovation Lab, located in the Roberto...

Read more

Innovative genome technology for improving the diagnosis of a rare genetic disease

A new research could transform how certain rare genetic diseases, including X-linked acrogigantism (X-LAG), are diagnosed. According to the study,...

Read more

Maria Rescigno elected corresponding member of the Accademia dei Lincei

Prof. Maria Rescigno, Vice Rector for Research at Humanitas University and Deputy Scientific Director for Basic Research at IRCCS Humanitas...

Read more

Carolina Greco Awarded the ERC Starting Grant to Study Circadian Clocks’ Role in Heart Failure

A project led by Humanitas University researcher Carolina Greco, who has been awarded a prestigious ERC Starting Grant of 1.7...

Read more

Adoptive Cell Therapies: How Salt Could Awaken T Cells’ Anti-Tumor Activity Before Infusion

A study led by Enrico Lugli reveals an unexpected potential for a readily available compound: sodium chloride, commonly known as...

Read more

PTX3 is a Predictive Marker of Co-infection in Hospitalized Patients

A recent study conducted by Humanitas researchers on patients hospitalized for Covid-19 shows that the level of PTX3 in the...

Read more

A novel approach to treat heart failure receives investment from Extend

Humanitas scientists have designed a novel therapeutic approach to treat heart failure based on immuno-modulation. To further develop the technology,...

Read more